Bogle Investment Management’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-164,125
Closed -$4.68M 334
2019
Q2
$4.68M Sell
164,125
-31,710
-16% -$792K 0.37% 98
2019
Q1
$4.9M Buy
195,835
+74,365
+61% +$1.42M 0.38% 96
2018
Q4
$1.53M Buy
121,470
+54,759
+82% +$648K 0.12% 179
2018
Q3
$637K Buy
+66,711
New +$736K 0.05% 228
2015
Q1
Sell
-16,106
Closed -$155K 422
2014
Q4
$155K Sell
16,106
-49,138
-75% -$383K 0.01% 337
2014
Q3
$636K Buy
+65,244
New +$856K 0.04% 277

Other funds holding VCYT

Bogle Investment Management's VCYT Position: Q3 2019 in Review

Bogle Investment Management sold out of Veracyte (VCYT) in Q3 2019, closing a stake of 164,125 shares — an estimated $4.68M sold.

Bogle Investment Management first reported a position in VCYT in Q3 2014 and held it in 6 quarters. The position peaked at $4.9M in Q1 2019. 187 funds tracked by Wall St. Rank hold VCYT as of Q3 2019.

  • Bogle Investment Management reported no remaining Veracyte position as of Q3 2019 after selling out during the quarter.
  • Bogle Investment Management sold 164,125 Veracyte shares in Q3 2019, an estimated $4.68M.
  • Bogle Investment Management first reported a position in Veracyte in Q3 2014 and held it in 6 quarters.
  • Bogle Investment Management's Veracyte position peaked at $4.9M in Q1 2019.
  • 187 funds tracked by Wall St. Rank held Veracyte as of Q3 2019.

Based on Bogle Investment Management's 13F filing for Q3 2019, filed 13 Nov 2019.